Pharmaceutical Filtration Market

Updated on : February 14, 2023

The global pharmaceutical filtration market In terms of revenue was estimated to be worth $13.5 billion in 2023 and is poised to reach $26.2 billion by 2028, growing at a CAGR of 14.2% from 2023 to 2028.

Growth in the global market can be attributed to factors such as the expanding biopharmaceutical industry, increased R&D spending by the government and top companies in pharmaceutical and biotechnology industries, rapidly growing adoption of single-use technologies, multiple product launches by leading market players, scrutiny for purity requirements by end users, and growing advances in nanofiber technology. However, membrane fouling and huge capital investment required to set up new production facilities are expected to adversely impact market growth.

Attractive Opportunities in the Pharmaceutical Filtration Market

To know about the assumptions considered for the study, Request for Free Sample Report

Pharmaceutical Filtration Market Dynamics

DRIVERS: Rising R&D spending in pharmaceutical and biotechnology industries

Pharmaceutical companies invest in R&D to deliver high-quality and innovative products in the market. The trend suggests that the top pharmaceutical companies are increasing their R&D efficiencies through heavy R&D investments. According to Evaluate Pharma, worldwide pharmaceutical R&D spending was valued at USD 144 billion in 2014, and this figure is estimated to reach USD 285 billion by 2028. As pharmaceutical filtration products, such as single-use and reusable filtration systems, membrane filters, depth filters, filtration assemblies, and other filtration products are used for the filtration and separation of molecules during R&D and pilot-scale operations, the increasing pharmaceutical R&D expenditure is expected to drive the growth of this market during the forecast period.

RESTRAINTS: Requirement of high capital investments for new production facilities

High capital investment is imperative for manufacturing filtration systems or equipment. Additional requirements such as technical know-how and skilled personel add up to the overall manufacturing costs. The price of large tangential tangential flow filtration (TFF) systems is more than USD 200,000, whereas investment to set up an entire production facility including downstream and upstream processes costs more than USD 200 million. Capital intensive nature of this market may limit the entry of smaller players into the market.

OPPORTUNITIES: Growth opportunities in emerging economies

Emerging countries such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the global market. The booming biopharmaceutical sector in these countries, an increased risk of pandemics (such as swine flu and COVID-19), less-stringent regulatory guidelines, growing economic strength and population, and the low manufacturing cost advantage are the major factors that are attracting market players to set up and expand their presence in these countries. Emerging economies are densely populated, with the population mark crossing 2 billion in recent years (Source: The World Bank Group). This has created opportunities for the expansion of the pharmaceutical industry in this region, which in turn is driving the demand for pharmaceutical filtration products.

China is estimated to be a high-growth market for bioprocessing products due to the growing government support and private investments in the country. Companies in China are increasingly making biologics-related investments and hiring a skilled workforce for their operations. Also, R&D investments in markets such as India and Brazil have increased significantly over the last few years. To capitalize on the available growth opportunities, key players are establishing new facilities, R&D centers, and innovation centers in these emerging countries.

CHALLENGES: Survival of small players and new entrants

The global market is highly consolidated, with top players such as Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), and 3M Company (US) holding a major market share in 2022. These established players offer a wide range of filtration products in various applications, such as sterile filtration, protein purification, and viral clearance. Furthermore, the top players in this market are large and well-established and have a high degree of brand loyalty. New entrants in this market have to compete with existing players and set themselves apart by developing innovative product offerings and advanced technologies. The high degree of consolidation thus acts as a major entry barrier for new entrants.

The membrane filters segment dominated pharmaceutical filtration Market in 2022

Based on type, the market is segmented into three major segments, namely, membrane filters, depth filters, and other filters. In 2022, membrane filtration segment dominated the market. The reason for the domination of these filters is that the membrane filters offer a number of advantages over other types of filters, including ease of installation in large and small systems; availability of products in a variety of polymers, pore sizes, diameters, and surface types for site-specific applications; high throughput, accuracy, and flow rate; lower filtration time and no risk of membrane fouling; and minimal cross-contamination. Membrane filers also adhere to the GMP manufacturing practices of pharmaceutical drugs. Owing to these advantages, the adoption of membrane filters is growing in the pharmaceutical industry.

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for the Pharmaceutical filtration Market in 2022.

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global market, followed by Europe and the Asia Pacific. The largest share of this segment can be attributed to the factors such as the existence of key biopharmaceutical manufacturing facilities in the region, growing number of drug development projects, the coexistence of well-established healthcare market with significant R&D budget, and the presence of a well-established intellectual property system for innovative biologics.

Key players in the Pharmaceutical Filtration Market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US).

Pharmaceutical Filtration Market Report Scope:

This report categorizes the pharmaceutical filtration market into the following segments and sub-segments:

By Product

• Filters
• Systems
• Other Filtration Products

By Filters

• Membrane Filters
• Polyethersulfone (PES)
• Polyvinylidene Difluoride (PVDF)
• Nylon
• Polyetrafluoroethylene (PTFE)
• Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
• Polycarbonate Tracked Etched (PCTE)
• Other Materials ( polypropylene (PP), cellulose nitrate (CN), regenerated cellulose (RC), gelatin, PETE, and Polyvinylchloride (PVC))
• Depth Filters
• Diatomaceous Earth
• Cellulose
• Activated Carbon
• Perlite
• Other Depth Filter Media (glass fibers, quartz, borosilicate, and resin binders)
• Other Filters ( prefilters, bag filters, and magnetic filters)

By Systems

• Single Use
• Reusable

By Other Filtration Products

• Filtration Assemblies
• Filter Holders
• Filtration Accessories

By Technique

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other Techniques (Reverse osmosis and Ion exchange)

By Type

• Sterile Filtration
• Non-Sterile Filtration

By Application

• Pharmaceutical Filtration Mcarket, by Final Product Processing
• Active Pharmaceutical Ingredient (API) Filtration
• Protein Purification
• Vaccine and Antibody Processing
• Formulation and Filling Solutions
• Viral Clearance

By Raw Material Filtration

• Media Buffer Filtration
• Prefiltration
• Bioburden Testing
• Cell Separation
• Water Purification
• Air Purification

By End Scale of Operation

• Manufacturing Scale
• Pilot Scale
• R&D Scale

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • 281">Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
  • Brazil
  • RoLATAM
• Middle East and Africa (MEA)

Recent Developments

• In January 2023, Sartorius AG (Germany) and RoosterBio, Inc. (US) signed a collaboration deal to provide purification solutions and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius will provide its scalable filtration equipment, such as SartoflowSmart and Sartoflow Advanced, for the clarification, concentration, and formulation of exosomes.
• In June 2022, Donaldson Company Inc. (US) acquired Purilogics, LLC (US), an early-stage biotechnology company that manufactures membrane chromatography products. Through this acquisition, the company will have access to the purification tools for a wide range of biologics, including mRNA, plasmid DNA, viral particles, monoclonal antibodies, and proteins that Purilogics offers.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst